NCT06694974View on ClinicalTrials.gov

Liver Fibrosis Assessment in Diabetic Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

540

Participants

Timeline

Start Date

November 22, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Type 2 DiabetesMetabolic Dysfunction-Associated Steatotic Liver Disease
Interventions
BEHAVIORAL

APP calculation for FIB-4

the investigators plan to use the smartphone App for FIB-4 calculation and notify the patients.

BEHAVIORAL

Standard Care (in control arm)

The standard group proceeds as regular practice

Trial Locations (1)

100

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT06694974 - Liver Fibrosis Assessment in Diabetic Patients | Biotech Hunter | Biotech Hunter